524632 — Shukra Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹16.94bn
- IN₹16.84bn
- IN₹325.87m
Annual cashflow statement for Shukra Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.978 | 10.2 | 44.4 | 199 | 133 |
| Depreciation | |||||
| Non-Cash Items | -0.337 | 2.5 | -2.35 | -5.01 | -8.85 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -10 | 50.6 | -28.7 | -266 | -75.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5.37 | 79.9 | 31.7 | -52 | 79.2 |
| Capital Expenditures | -17.9 | -15.5 | -44.9 | -17.6 | -27.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.04 | 0.22 | 0.639 | 5.59 | 14.8 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -18.9 | -15.3 | -44.3 | -12 | -12.6 |
| Financing Cash Flow Items | 0 | -2.81 | -2.56 | -2.85 | -5.95 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17.4 | -66.8 | 49.4 | 124 | -45.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.78 | -2.15 | 36.8 | 60.1 | 21.4 |